Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

Next Previous
X
Search
Trial Profile

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Acronyms SCALE IBT
  • Sponsors Novo Nordisk

    • Most Recent Events

    • 18 Mar 2019 Results of a pre-specified secondary analysis assessing athe effect of liraglutide 3.0 mg on weight loss, presented at the 101st Annual Meeting of the Endocrine Society
    • 18 Mar 2019 Results of a pre-specified exploratory sub-analysis determining the individual contributions of adherence to study medication, and to the adjunct diet and physical activity interventions on weight change, presented at the 101st Annual Meeting of the Endocrine Society.
    • 18 Mar 2019 Primary endpoint (Proportion of subjects losing at least 5% of baseline body weight) has been met, according to the results presented at the 101st Annual Meeting of the Endocrine Society.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top